Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Hypertrophic Scarring in Epicanthoplasty
NCT03294382Phase 3Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Apr 2017
- Primary completion
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in Hypertrophic Scar (HS), sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT03294382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03294382.